Contipro Competitors and Similar CompaniesClear all

Contipro's competitors and similar companies include Sai Life Sciences, Zambon, Sirona Biochem and Nanjing Legend Pharmaceutical & Chemical.

	Contipro Contipro is a biotech company that manufactures hyaluronic acid for pharmaceutical and cosmetic industries.	Sai Life Sciences Sai Life Sciences is a provider of drug discovery, development, and manufacturing services for pharmaceutical and biotechnology clients.	Zambon Zambon is a company active in the pharmaceutical and chemical industry.	Sirona Biochem Sirona Biochem is a biotech company that develops the platform technology of fluorination chemistry.	Nanjing Legend Pharmaceutical & Chemical Nanjing Legend Pharmaceutical & Chemical (南京康瑞医药化工有限公司) is a company that specializes in the development of pharmaceuticals and fine chemicals.
Founding Date	Founding Date 1990	Founding Date 1999	Founding Date 1906	Founding Date 2009	Founding Date N/A
Type	Type Private	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech chemicals drug development pharma	Tags Healthcare biotech chemicals drug development pharma	Tags Healthcare biotech chemicals drug development pharma	Tags Healthcare biotech chemicals cosmetics drug development pharma	Tags Healthcare biotech chemicals drug development life sciences pharma
Locations	Locations Dolní Dobrouč, CZ HQ	Locations Turkapally, IN HQ	Locations Milan, IT HQ Sao Paulo, BR Haikou, CN Avrillé, FR Jakarta, ID Vicenza, IT Cadempino, CH see more	Locations Vancouver, CA HQ	Locations Nanjing Shi, CN HQ
Employees	Employees 1591% increase	Employees 3,6672% increase	Employees 2,5431% increase	Employees N/A	Employees N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹16.6b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $35k (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₹5.1b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₹11.8b (FY, 2025)	Gross profit N/A	Gross profit $35k (FY, 2023)	Gross profit N/A
Net income	Net income N/A	Net income ₹1.7b (FY, 2025)	Net income N/A	Net income ($2.5m) (FY, 2023)	Net income N/A